July 17, 2018 Amring Pharmaceuticals Inc. (Amring), a generic pharmaceutical company, today announced the release of its latest product, Biolon OVD (ophthalmic viscosurgical device). Amring is excited to offer this new, cost-effective device and position itself in the...
June 30, 2017 Amring Pharmaceuticals Inc. today announced that it is a recipient of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement company. One of 11 suppliers to receive the award this year, Amring Pharmaceuticals Inc. was recognized...
March 1, 2017 Amring Pharmaceuticals Inc. acquired six ANDA’s from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture between Luitpold Pharmaceuticals, Inc. and Alphagen Laboratories Inc. The acquired ANDAs include niche otic and ophthalmic...
April 29, 2016 Amring Pharmaceuticals Inc. and Integrated Commercialization Solutions Inc. (ICS) have agreed to expand the current list of provided services to include Account Receivables and Cash Applications. This consolidates the order to cash process to one...
Recent Comments